Novo Nordisk will be selling the new 7.2-mg dose under the brand name Wegovy HD. The FDA's decision fell under a new pilot program intended to grant certain companies improved access and quicker approvals.
The Cardiovascular Business Forty Under 40 Class of 2026 represents an accomplished group of clinicians, researchers, entrepreneurs and administrators who are redefining what cardiovascular leadership looks like under the age of 40.
The Amsterdam-based imaging giant is working with the AI powerhouse to create an AI-generated preview of MRI scans, before the acquisition even begins.
Market forces like competition cannot stem the urge to merge among and between payers and providers, so neither will they staunch the price hikes in premiums.